Quaker BioVentures II LP

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Quaker BioVentures II LP
CIK #0001497725
EDGAR Form CIK 2011 - 2026
3 [0001497725]
4 [0001497725]
SC 13D [0001497725]
SC 13G [0001497725]
Form 13D/13G Filer Form 13D/13G Subject Filed
Quaker BioVentures II LP TELA Bio Inc [2020-02-14]
Quaker BioVentures II LP Transenterix Inc [2014-02-13]
Quaker BioVentures II LP Innovus Pharmaceuticals Inc [2014-01-09]
Quaker BioVentures II LP Nupathe Inc [2012-10-05]
Quaker BioVentures II LP Durata Therapeutics Inc [2012-07-27]
Quaker BioVentures II LP Horizon Pharma Inc [2012-03-09]
Quaker BioVentures II LP Cempra Inc [2012-02-17]
Form 3/4/5 Subject 2011 - 2026
TELA Bio Inc
Quaker BioVentures Capital II LP
Quaker BioVentures II LP
Nupathe Inc
Melinta Therapeutics Inc /New/
Horizon Therapeutics Public Ltd Co
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
TELA Bio Inc TELA
Common Stock
2022-06-02 Other 1,751,100 $0.00
TELA Bio Inc TELA
Series A Preferred Stock · derivative
2019-11-13 Conversion 8,530,145 $0.00
TELA Bio Inc TELA
Common Stock
2019-11-13 Conversion 516,947
TELA Bio Inc TELA
Common Stock
2019-11-13 Conversion 345,489
TELA Bio Inc TELA
Warrant (right to buy) · derivative
2019-11-13 Conversion 446,813 $0.00
TELA Bio Inc TELA
Warrant (right to buy) · derivative
2019-11-13 Conversion 446,813 $0.00
TELA Bio Inc TELA
Series B Preferred Stock · derivative
2019-11-13 Conversion 12,763,434 $0.00
TELA Bio Inc TELA
Common Stock
2019-11-08 Buy 153,846 $13.00 1,999,998
Nupathe Inc PATH
Common Stock
2014-02-21 Tender 5,321,193 $3.65 19,422,354
Nupathe Inc PATH
Warrant (right to purchase) · derivative
2014-02-21 Other 2,500,000 $1.65 4,125,000
Melinta Therapeutics Inc /New/ CEMP
Common Stock
2013-06-19 Buy 265,000 $7.00 1,855,000
Nupathe Inc PATH
Series A Preferred Stock · derivative
2013-02-05 Conversion 2,500
Nupathe Inc PATH
Common Stock
2013-02-05 Conversion 2,500,000 $2.00 5,000,000
Nupathe Inc PATH
Warrant (right to buy) · derivative
2012-10-23 Buy 2,500,000
Nupathe Inc PATH
Series A Preferred Stock · derivative
2012-10-23 Buy 2,500
Horizon Therapeutics Public Ltd Co HZNP
Common Stock
2012-10-09 Option exercise 546,198 $0.01 5,462
Horizon Therapeutics Public Ltd Co HZNP
Common Stock Warrants · derivative
2012-10-09 Option exercise 546,198 $0.00
Horizon Therapeutics Public Ltd Co HZNP
Common Stock
2012-09-07 Other 208,334 $0.00
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com